Calita Nutraceuticals Ltd

Calita Nutraceuticals Ltd, based in Rugby, UK, is a small holding company with an active status. Founded four years ago in December 2020, it employs 26 people and holds £592,198 in assets. The company has two directors and two owners, and boasts a perfect 5.0 Google rating from one review. It’s a regular importer of pharmaceutical products, with 18 months of import activity recorded, the last in February 2025.

The company’s website reveals it operates as a full-service contract manufacturer of dietary supplements. Calita Nutraceuticals offers manufacturing, private label, and packaging services, catering to companies seeking to get their desired products to customers. It highlights a state-of-the-art, MHRA GMP-certified facility, emphasizing strict quality control standards and the use of high-quality raw materials. The site also mentions a full-service private label team offering product development, custom formulation, and packaging design.

Financially, Calita Nutraceuticals Ltd shows some concerning trends. Creditors have risen significantly by 470% within the last year, reaching £17,000, while accrued liabilities have increased. Net assets have also decreased by 85%, to -£670,000. Bank borrowings have increased slightly, and cash reserves have grown by 71% to £62,000. Trade debtors have doubled, suggesting potential issues with customer payments. The company meets the criteria for a small business, with turnover under £10.2m, assets under £5.1m, and fewer than 50 employees. Despite this, the increase in liabilities and the negative equity suggest the company is burning through money, though it’s not clear if this is a typical startup phase or a more serious issue. No auditor is mentioned, which is common for small companies. The increase in average number of employees from 26 to 36 is also a notable change.

Registered in England/Wales under the registration number 13072839, with a registered address at CV21 3XH, England, Rugby, Unit 1b, Great Central Industrial Estate, Great Central Way.

WARNING:The numbers have been rounded for simplicity and may be inaccurate.Please, refer to the latest financial report for verification.